Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Phase 1 Completed 56 enrolled University of Chicago National Cancer Institute (NCI) · collab

NaSingle-groupOpen-labelTreatment

Summary

This clinical trial studies sirolimus in treating patients with solid tumors that are metastatic or cannot be removed by surgery. Sirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth

Timeline

Start: 2012-06-13
Primary completion: 2018-08-17
Completion: 2018-08-17

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sirolimus	Small molecule	—	Oral

Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Summary

Timeline

Drugs

Indications